Phytochemical products: rice bran

Phytochemical Functional Foods

Volumn , Issue , 2003, Pages 347-376

  Cheruvanky, Rukmini ^a  

^a NutraStar Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902937930     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-672-6.50021-6     Document Type: Chapter

References (123)

1. J F ADAMS and A ENGSTROM (2000) ‘Dietary intake of whole grains: US recommendation.’. Cereal Foods World 45 75-78.
2. M AKESHITA, S NAKAMURA, F MAKITA, S OHWADA, Y MIYAMOTO and Y MORISHITA (1992) ‘Antitumor effects of RBS (rice bran saccharide) on ENNG induced Carcinogenisis.’. Biotherapy, (Dodrecht) 4(2), 139-145.
3. J W ANDERSON, D A DEAKINS, T L FLOORE, B M SMITH and S E WHITIS (1990) ‘Dietary fiber and coronary heart disease.’. Critical Rev Food Sci and Nutr 55 436-442.
4. T AKIHISA, K YASUKAWA, M YAMAMURA, M UKIYA, Y KIMURA, N SHIMIZU and K ARAI (2000) ‘Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects.’. J Agri Food Chem 48 2313-2319.
5. A B AWAD and C S FINK (2000) ‘Phytosterols as anticancer dietary components: Evidence and mechanism of action.’. J Nutr 130(9), 2127-2130.
6. P J D BOUIC, S ETSEBETH, R W LIEBENBERG, C F ALBRECHT, K PEGEL and P P VAN JAARSVELD (1996) ‘Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: Implications for their use as an immunomodulatory vitamin combination.’. International J Immunopharmacology 18(12), 693-700.
7. J BRUNI (1988) Monograph on Gamma Oryzanol: The Facts Houston, TX: Claudell Publishers 1-62.
8. BURKS A W, HELM R M (1994) ‘Hypoallergenicityof rice protein.’ Presented at the Annual Meeting of the American Association of Cereal Chemists. Nashville, TN.
9. G BUSHKIN and E BUSHKIN (January 2002) ‘Ancient alternative medicine: Time-honored native natural healthcare system.’. Health Products Business 8-13.
10. D A BUTTERFIELD, A MARINA, K JAROSLAW and S ANTONIO (2002) ‘Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure activity studies.’. J Nutri Biochem 13(5), 273-281.
11. D CERIELLO, A GIUGLIANO, C QUATRARO, G DONZELLA and P J DIPALO LEFEBVRE (1991) ‘Vitamin E Reduction of Protein Glycosylation in Diabetes.’. Diabetic Care 14(1), 68-72.
12. M CHANDALIA, A GARG, D LUTJOHANN, K VON BURGMANN, S M GRUNDY and L J BRINKLEY (2000) ‘Beneficial effects of high dietary fiber intake in patients with Type 2 Diabetes Mellitus.’. N Eng J Med 342 1392-1398.
13. D C COCKERIL and L R BUCCI (1987) ‘Increases in muscle grith and decreases in body fat associated with a nutritional supplemental program.’. Chirop. Sports Ed I(2), 73.
14. L COLODNY and R HOFFMAN (1998) ‘Inositol clinical application for exogenous use.’. Altern Med Rev 3(6), 432-447.
15. J H CUMMINGS (1992) ‘Fecal weight, colon cancer and dietary fiber intake of non-starchy polysaccharide(dietary fiber).’. Gastroenterology 103 1783-1789.
16. R E DAVIS, J S CALDER and D H CURNOW (1976) ‘Serum pyridoxal and folate concentrations in diabetics.’. Pathology 8 151-156.
17. H FAN, T MORIOKA and E ITO (2000) ‘Induction of apoptosis and growth inhibition of cultured human endometrial adenocarcinoma cells (Sawano) by an anti-tumor lipoproteinfraction of rice bran.’. Gynacol, Oncol 76(2), 170-175.
18. First International Symposium on ‘Disease Prevention by IP6 and other Rice Components.’ (1998) June 8-9, Taragaike, Kyoto, Japan.
19. M FOLINO, A MCINTYRE and G P YOUNG (1995) ‘Dietary fibers differ in their effect on large bowel epithelial proliferation-dependent events in rats.’. J Nutr 125(6), 1521-1528.
20. Food and Nutrition Board Recommendations (2001) ‘Dietary reference intakes - dietary fiber.’ Institute of Medicine, Washington D C, National Academy Press, 1-64.
21. C W FRITSCH and J A GALE (1977) ‘Hexanal as a measure of rancidity in low fat foods.’. JAOCS 54 225-228.
22. J FUKUSHI (1996) ‘Edible rice bran oil III: antioxidant effects of gamma oryzanol.’. Hokkaidoritus Elsei Kenkyushoho 16 111.
23. A L GERHARDT and N B GALLO (1998) ‘Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans.’. J Nutr 128(5), 865-869.
24. E GRAF (1992) ‘Antioxidant potential of ferulic acid.’. Free Radical Biol & Med 13(4), 435-448.
25. N GUTHRIE, A GAPOR, A F CHAMBERS and K K CARROL (1997) ‘Inhibition of proliferation of estrogen receptor negative MDA-MB-435 and positive MCF-7human breast cancer cells by palm oil tocotrienols and tomoxifin alone and in combination.’. J Nutr 127(3), 544S-548S.
26. M HEGSTED and C S KOUSIK (1994) ‘Rice bran and rice bran oil may lower heart disease risk by decreasing cholesterol synthesis in the body.’. Lousiana Agriculture 37(2), 16-17.
27. R M HELM and A W BURKS (1996) ‘Hypoallergenicity of rice protein.’. Cereal Foods World 4(11), 839-843.
28. HETTIARACHCHY N S (1999) ‘Hypoallergenicity of stabilized rice bran products.’ RiceX Company Report.
29. HIKINO H, HAYASHI T (1989) J P 1066203A.
30. H HIKINO, M TAKAHASHI, Y OSHIMA and C KONNO (1988) ‘Isolation and hypoglycemic activity of oryzabrans A, B, C, and D, glycans of oryza sativa bran.’. Planta Med 54(1), 1-3.
31. Y HIRAGA, N NAKATA, H JIN, S ITO, R SATO, A YOSHIDA, T MORI, M OZEKI and Y IKEDA (1993) ‘Effect of the rice bran-derived phytosterol cycloartenol ferulic acid ester on the central nervous system.’. Arzneimittel-Forschung 43(7), 715-721.
32. C HUANG, W Y MA, S S HECHT and Z DONG (1997) ‘Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3’ kinase.’ [published erratum appears in Cancer Res 1997 57(22): 5198]. Cancer Res 57 2873-2878.
33. A HUDSON, P A DINH, T KOKUBUN, M S SIMMONDS and A GESCHER (2000) ‘Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells.’. Cancer Epidemiol Biomarkers Prev 9(11), 1163-1170.
34. T ICHIKAWA (1974) ‘Administration of gamma oryzanol to women suffering from postmenopausal syndrome. Changes of hormone levels before and after administration.’. J New Drugs Clinics 23 40.
35. T ICHIRO, F AKIHIKO, K DAIJI, O RYUJI, S IKUO and S ATSUSHI (2002) ‘Short and long term effects of ferulic acid on blood pressure in spontaneously hypertensive rats.’. American J of Hypertension 15(part 1), 351-357. 4
36. T IEIRI, N KASE, Y HASHIGAMI, H KOBORI, T NAKAMURA and S SHIMODA (1982) ‘Effect of γ-oryzanol on the hypothalamus-pituitary axis in the rat.’ (Japanese). Nippon Naibunpi Gakkai Zasshi 20(10), 1350-1356.
37. E ITO, S TAKEO, H KADO, H YAMAMOTO, N WATENBE, M KAMIMURA, E SOMA, K UCHIDA, Y MORI and T MORINAGA (1985) ‘Studies on an antitumor polysaccharide RBS derived from rice bran. 1. Preparation, physico-chemical properties, and biological activities of RBS.’. Yakugaku Zasshi 105(2), 188-193.
38. R A JACOB and M E SWENDSEILD (1996) ‘Niacin.’. E E Ziegler, L J Filer, Jr,(Eds) Present Knowledge in Nutrition Seventh Eds Washington D C: ILSI Press 184-190.
39. A JAHNEN, H HEYNCK, B GERTZ, A CLABEN and A HESSE (1992) ‘Dietary fiber: the effectiveness of a high bran intake in reducing renal calcium excretion.’. Urol Res 20 3-6.
40. T JALILI, R E C WILDMAN and D M MEDEROS (2000) ‘Nutraceutical role of dietary fiber.’. J Nutraceutical, Functional and Medical Foods 2(4), 19-34.
41. R JARIWALLA (1999) ‘Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid lowering agent.’. Anticancer Research 19 3699-3702.
42. D A JENKINS (1978) ‘Dietary fibers and fiber analogues and glucose tolerance importance of viscosity.’. Brit Med J 1 1392-1394.
43. C L JONE and V GONZALEX (1978) ‘Pyridoxine deficiency, a new factor in daiabetic Neuropathy.’. J Amer Podiatory Assoc 68 646-653.
44. B O JULIANO (1985) ‘Rice bran.’. B O Juliano,(Eds) Rice Chemistry and Technology Amer St Pauls, Minn. USA: Amer Assoc Cereal Chemists Inc. 647-687.
45. T S KAHLON and F I CHOW (1997) ‘Hypocholesterolemic effect of oat, rice and barley dietary fibers and fractions. Review.’. Cereal World 42(2), 86-92.
46. M KAMIMURA, S TAKAHASHI and S SATO (1964) ‘Influence of gamma oryzanol on the skin capillary circulation.’. Bitamin 30 341. (Chem. Abstr., 1965, 62: 5783e)
47. G S KELLY (1999) ‘Larch arabinogalactan: Clinical relevance of a novel immune-enhancing polysaccharide.’. Altern Med Rev 4(2), 96-103.
48. P M KIDD (1996) ‘Phosphatydal choline: a superior protectant against liver damage.’. Altern Med Rev 1(4), 258-274.
49. H KIKUZAKI, M HISAMOTO, K HIROSE, K AKIYAMA and H TANIGUCHI (2002) ‘Antioxidant properties of ferulic acid and its related compounds.’. J Agri Food Chem 50(7), 2161-2168.
50. K F KLIPPEL, D M HILTL and B SCHIPP (1997) ‘A multicentric placebo controlled double-blind clinical trial of beta-sitosterol for the treatment of benign prostate hyperplacia.’. British J Urology 80(3), 427-432.
51. M-H LAI, Y-J LIN, M-L HUNG and H-H CHENG (2001) ‘Dietary rice bran improves the glycemic response in rats with Streptozotocin-induced diabetes.’. Nutritional Sciences Journal 26(3), 159-170.
52. R S LEES and A LEES (1976) ‘Sitosterol therapy on plasma lipid and lipoprotein Concentrations.’. H Greten,(Eds) Lipoprotein Metabolism Berlin: Springer 119-124.
53. J E LEKLEM (1998) ‘Vitamin B6 functions in humans.’. J E Leklem,(Eds) Clinical and physiological application of vitamin B6 Reynolds, New York: Liss 297-320.
54. A H LICHTENSTEIN, L M AUSMAN, W CARRASCO, L J GUALLEIRI, J L JENNER, J M ORDOVAS, R J NICOLOSI, B R GOLDIN and E J SCHAEFER (1994) ‘Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans.’. Arterioscleroses and Thrombosis 14(4), 549-556.
55. Life Sciences Newsletter (2000) ‘Fiber: an ancient secret rediscovered.’ Issue 25, PO Box 2016, Sedona AZ.
56. LIN J K S, LEE F, HUANG Y T, LIN-SHIAU S Y (1995) ‘Signal transduction and oncogene expression mediated by reactive oxygen species.’ In Proceedings of the International Symposium on Natural Antioxidants - Molecular Mechanisms and Health Effects. Eds Packer, L, Traber, M G, Xin, W Champaign, I L, USA: AOCS Press, 303-19.
57. MANORAMA R (1993) Hepatic Drug Metabolizing Enzymes of Rice Bran Oil Fed Rats. Ph D. Thesis submitted to Osmania University, Hyderabad, India.
58. MASAYOSHI S, MASAYASU T, SABURO K (1987) J P 62201821A.
59. G H MCINTOSH (2001) ‘Cereal foods, fibers and the prevention of cancers.’. Australian Journal of Nutrition and Dietetics 58(Suppl. 2), S35-S48.
60. MCPEAK P, RUKMINI C, REDDY SASTRY C (2001) ‘Supportive therapy for diabetes, hyperglycemia and hypoglycemia.’ US Patent 6,303,586 B1.
61. M MEYDANI (1995) ‘Vitamin E.’. The Lancet 345 170-175.
62. H MIYOSHI, Y OKUDA and H KOSHI (1986) ‘Effect of rice fiber on fecal weight, apparent digestibility of energy and fat and degradation of neutral detergent fiber in young men.’. J Nutr Sci Vitaminol 32 581.
63. N MIYOSHI, Y KOYAMA, Y KATSUNO, S HAYAKAWA, T MITA, T OHTA, K KAJI and M ISEMURA (2001) ‘Apoptosis induction associated with cell cycle dysregulation by rice bran agglutinin.’. J Biochem, (Tokyo) 130 799-805.
64. R A MOREAU, R A NORTON and K B HICKS (1999) ‘Phytosterol and phytostenol lower cholesterol.’. INFORM 10(6), 572-577.
65. MORITA S (1986) ‘Cosmetic creams containing Oryzanol.’ J P 8665810.
66. S NAKAMURA (1992) ‘Fundamental study on influence of rice bran saccharide on ENNG carcinogenesis and immunocompetence of rat.’. J Jap Soc for Cancer Theropy 27(1), 13-20.
67. S NAKAZAWA, K IMAI and Y YAMAMOTO (1977) ‘Clinical studies on γ-oryzanol in the treatment of autonomic instability with abdominal symptoms.’. Japanese J. Psychosom Med 17(4), 101-108.
68. K NESARETNAM, R STEPHEN, R DILS and P DARBRE (1998) ‘Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.’. Lipids 33(5), 461-469.
69. R J NICOLOSI, E J ROGERS, L M AUSMAN and F T ORTHOEFER (1993) ‘Rice bran oil and its health benefits.’. W E Marshal, J I Wadsworth,(Eds) Rice Science and Technology New York: Marcel Dekker 421-437.
70. NIKI E, IWATSUKI M, KATO Y (1995) ‘Dynamics of antioxidation by phenolic antioxidants.’ In Proceedings of the Internatonal Symposium on Natural Antioxidants - Molecular Mechanisms and Health Effects. Eds Packer, L, Traber, M, Xin, W, Champaign, II, USA: AOCS Press, 1-8.
71. NOBORU K K, YUSHO T (1997) ‘Oryzanol containing cosmetics.’ J P 7032078 (Chem Abstr. 1998, 14269x).
72. F L NORMAND, R L ORY and R R MOD (1987) ‘Binding of bile acids and trace minerals by soluble hemicelluloses of rice: The ability of rice fiber components to bind bile acids may play a role in lowering serum cholesterol.’. Food Technology 41(2), 86-90.
73. F T ORTHOEFER (1996) ‘Rice bran oil: a healthy lipid source.’. Food Technology 50(12), 62-64.
74. T OHKAWA, S EBISUNO, M KITAGAWA, S MORIMOTO, Y MIAZAKI and S YASUKAWA (1984) ‘Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies.’. J of Urology 132 1140-1145.
75. N K OZER, D BOSCOBOINIK and A AZZI (1995) ‘New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis.’. Biochem Mol Biol Int 35(1), 117-124.
76. PACKER L (1995) ‘Antioxidant defenses in biological systems: an overview.’ In Proceedings of The International Symposium on Natural Antioxidants - Molecular Mechanisms and Health Effects. Eds Packer, L, Traber, M G, Xin, W, Champaign, IL, USA: AOCS Press 9-23.
77. R A PARKER, B C PEARCE, R W CLARK, D A GORDON and J J WRIGHT (1993) ‘Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy 3-methyl-glutaryl-coenzyme A reductase.’. J Biol Chem 268 11230-11238.
78. J PRAKASH (1996) ‘Rice bran properties and food uses.’. Critical Rev Food Sci and Nutr 36(6), 537-552.
79. N QURESHI and A A QURESHI (1992) ‘Tocotrienols: novel hypocholesterolemic agents with antioxidant properties.’. L Packer, J Fuch,(Eds) Vitamin E in Health and Disease New York: Marcel Dekker 245-267.
80. A A QURESHI, B A BRADLOW, W A SALSER and L D BRACE (1997) ‘Novel tocotrienols of rice bran modulate cardiovascular risk parameters of hypercholesterolemic humans.’. J Nutri Biochem 8 290-298.
81. A A QURESHI, S A SAMI, W A SALSER and F A KHAN (2001) ‘Synergistic effect of tocotrienol rich fraction (TRF 25) of rice bran and lovostatin on lipid parameters in hypercholesterolemic humans.’. J Nutri Biochem 12 318-329.
82. A A QURESHI, A S SAEED and A K FAROOQ (2002) ‘Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types 1 and 2.’. J Nutri Biochem 13 175-187.
83. D RAEDERSTORFF, V ELSTE, C AEBISCHER and P WEBER (2002) ‘Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters.’. Ann Nutr Metab 46 17-23.
84. T C RAGHURAM, U BRAHMAJI RAO and C RUKMINI (1989) ‘Studies on the hypolipidemic effects of dietary rice bran oil in human subjects.’. Nutrition Reports International 39 889-895.
85. REDDY SASTRY C V, RUKMINI C (1997) ‘Stability studies on stabilized rice bran under accelerated conditions for twelve weeks.’ (RiceX Company Report).
86. REDDY SASTRY C V, RUKMINI C, IKE LYNCH, MCPEAK D (1999) ‘Process for obtaining micronutrient enriched rice bran oil.’ US Patent 5,985,344 RiceX Company, Proprietary Technology.
87. N RONG, L M AUSMAN and R J NICOLOSI (1997) ‘Gamma-oryzanol decreases cholesterol absorption and aortic streaks in hamsters.’. Lipids 32(3), 303-309.
88. C RUKMINI (2000) ‘Bioactives in rice bran and rice bran oil.’. W R Bidlack, S T Omaye, M S Meskin, D K W Topham,(Eds) Phytochemicals as Bioactive Agents Lancaster PA: Technomic 213-239.
89. C RUKMINI and P KALPAGAM (1985) ‘Antimutagenic property of the unsaponifiable portion rice bran oil.’. D M Shankel, P E Hartman, T Kada, A Holaender,(Eds) Antimutagenesis and Anticarcinogenesis Mechanisms New York: Plenum Press 576.
90. C RUKMINI and T C RAGHURAM (1991) ‘Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil.’. J Am Coll Nutr 10 593-601.
91. RUKMINI C, REDDY SASTRY C, MCPEAK P, LYNCH I (2000) ‘Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.’ US Patent 6,126,943.
92. R M SAUNDERS (1986) ‘Rice bran: composition and potential food uses.’. Food Rev Int 8 415-498.
93. RUKMINI C, REDDY SASTRY C, MCPEAK P, LYNCH I (2002) ‘Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.’ US Patent 6,350,473 B1.
94. F SAURA-CALIXTO (1998) ‘Antioxidant dietary fiber product: A new concept and potential food ingredient.’. J Agri Food Chem 46 4303-4306.
95. G SEETHARAMIAH and N CHANDRASEKHARA (1989) ‘Studies on hpocholesterolemic activity of rice bran oil.’. Atherosclerosis 78 219-223.
96. G S SEETHARAMIAH and N CHANDRASEKHARA (1990) ‘Effect of gamma oryzanol on cholesterol absorption and biliary and fecal bile acids in rats.’. Ind J Med Res 92 471-475.
97. A M SHAMSUDDIN (1995) ‘Inositol phosphates have novel anti-cancer function1,2.’. J Nutr 125 725S-732S. Supplement
98. A M SHAMSUDDIN (1998) ‘IP6: Natures Revolutionary Cancer Fighter.’ New York: Kensington Publishing Corporation
99. A M SHAMSUDDIN, I VUCENIK and K E I COLE (1997) ‘Minireview IP6: A novel anticancer agent.’. Life Sciences 61(4), 343-354.
100. F SHIH and K W DAIGLE (2000) ‘Preparation and characterization of rice protein isolates.’. JAOCS 77(8), 885-889.
101. T SHIN, S J GODBER, D E MARTIN and H J WELLS (1997) ‘Hydrolytic stability and changes in vitamers and oryzanol of extruded rice bran during storage.’. J Food Sci 62(4), 704-729.
102. J A STORY and D KRITCHEVSKY (1976) ‘Dietary fiber and lipid metabolism.’. G A Spiller, R J Amen,(Eds) Fiber in Human Nutrition New York: Plenum Press 171-184.
103. SUGANO M (1979) ‘Antidandruff and anti-itching shampoo.’ J P 7936306 (Chem Abstr, 1979, 87: 78764a).
104. M SUGANO, N ISHIWAKI and K NAKASHIMA (1984) ‘Dietary protein-dependent modification of serum cholesterol level in rats: significance of Arginine/lysine ratio.’. Ann Nutr Metab 28 192-199.
105. M SUGANO and E TSUJI (1997) ‘Rice bran oil and Cholesterol Metabolism’. J. Nutr 12(7), 5215-5245.
106. M TAMAGAVA, Y SHIMIZU, T TAKAHASHI, T OTAKA, S KIMURA, H KADOWAKI, F UDA and T MIWA (1992) ‘Carcinogenecity study of γ-oryzanol in F 344 rats.’. Food Chemical Toxicology 30(1), 41-48.
107. S TAKENAKA (1992) ‘Hemicellulose in rice bran fiber reduces thymus atrophy in rats treated wih bis-tri-n-butyn oxide.’. Chemosphere 25(3), 327-334.
108. S TAKENAKA and Y ITOYAMA (1993) ‘Rice bran hemicellulose increases the peripheral blood lymphocytes in rats.’. Life Sciences 52(1), 9-12.
109. A L TAPPEL (1997) ‘Vitamin E as a biological lipid antioxidant.’. INFORM 8(4), 392-395.
110. A C TOMEO and M GELLER (1995) ‘Antioxidant effect of tocotrienols in patients with hyperlipidemia and carotid stenosis.’. Lipids 30 1179-1183.
111. J TOMLIN and N W READ (1988) ‘Comparison of the effects on colonic function caused by feeding rice bran and wheat bran.’. Eur J Clin Nutr 42(10), 857-861.
112. D L TOPPING, R J ILLMAN, P D ROACH, R P TRIMBLE, A KAMBOURIS and P J NESTEL (1990) ‘Modulation of hypolipidemic effect of fish oil by dietary fiber in rats: studies with rice bran and wheat bran.’. J Nutr 120(4), 325-330.
113. G TSUSHIMOTO, T SHIBAHARA, T AWOGI, E KANEKO, S SUTOU, K YAMAMOTO and H SHIRAKAWA (1999) ‘DNA damaging mutagenic, elastogenic and cell-cell communication inhibitory properties of γ-oryzanol.’. J Toxicol Sci 16 191-202.
114. K TSUTSUML, Y KAWAUCHI, Y KONDO, Y INOUE, O KOSHITANI and H KOHRL (2000) ‘Water extract of defatted rice bran suppresses visceral fat accumulation in rats.’. J Agri Food Chem 48(5), 1653-1656.
115. A O TZIANABOS (2000) ‘Polysaccharides as immunomodulators therapeutic agents: structure and biological function.’. Clinical Microbiol Rev 13(10), 523-533.
116. M URBERG and M B ZEMEL (1987) ‘Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans.’. Metabolism 36 896-899.
117. L VANDERHAEGHE and P J D BOUIC (2000) ‘The Immune System Cure: Optimize Your Immune System in 30 days - the Natural Way.’ New York: Kensington Publishing Corp
118. M WANG, N S HETTIARACHCHY, M QI, W BURKS and T SIEBENMORGEN (1999) ‘Preparation and functional properties of rice bran protein isolate.’. J Agri, Food Chem 47 411-416.
119. J A WESTSTRATE and G W MEIJER (1998) ‘Plant sterol enriched margarine and reduction of plasma and total LDL-cholesterol concentrations in normocholesterolemic and mildly hypercholesterolemic subjects.’. Eur J Clin Nutr 52(5), 334-343.
120. T M S WOLVER and D J A JENKINS (1993) ‘Effect of dietary fiber and foods on carbohydrate metabolism.’. G A Spiller,(Eds) Dietary Fiber in Nutrition Boca Raton, FL: CRC Press 111-152.
121. Z XU and S GODBER (1999) ‘Purification and identification of components of γ-oryzanol in rice bran oil.’. J Agri Food Chem 47 2724-2728.
122. Z XU, N HUA and S GODBER (2001) ‘Antioxidant activity of tocopherols, tocotrienols, and γ-oryzanol components from rice bran against cholesterol oxidation accelerated by 2, 2’-azobis(2-methylpropionamidine) dihydrochloride.’. J Agri Food Chem 49 2077-2081.
123. G YOSHINO, T KAZUMI, M AMANO, M TATEIWA, T YAMASAKI, S TAKASHIMA, M IWAI, H HATANAKA and S BABA (1989) ‘Effect of gamma oryzanol on hypolipidemic subjects.’. Curr Therapeutic Res 45(4), 543-550.